NVDA vs SLRX · P/E 58, rev $96.22B vs $4.9M cap
NVIDIA Corporation (NVDA) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
NVDA currently screens at market cap $4.40T and trailing P/E 58.2. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the NVDA and SLRX stock pages for the full models.
Not investment advice.